Loading...

Loading...

California Sues Drugmakers for Insulin Overcharging
By Rodrigo Andrade - Thu, 01/19/2023 - 12:00
The state is accusing top US insulin producers of abusing their market dominance to overcharge for the life-saving drug.
https://mexicobusiness.news/tag/eli-lilly
More Health
Raising Awareness on Food Labels: The Week in Health
By Antonio Gozain - Thu, 11/10/2022 - 10:00
The Partnership for Food Security protested in front of SCJN to defend a much-discussed law that makes labels on food packaging mandatory.
Bio Convention an Opportunity to Demonstrate Mexico’s Potential
By Victor Gabriel Sánchez - Wed, 06/29/2022 - 10:00
Ahead of the annual global bio convention, Victor Sanchez explains the opportunity for Mexico in this growing industry.
Mexico to Reach 40 Percent of Vaccinated Adults
By Miriam Bello - Thu, 06/24/2021 - 14:08
Vaccine rollouts slowed down in June, while the economic reopening and educational activities resumed.
Science Shines a Ray of Hope Upon the World
By Miriam Bello - Thu, 11/12/2020 - 16:25
After three positive advances regarding COVID-19 treatments and vaccines, the light at the end of the tunnel seems to draw nearer.
Eli Lilly Has an Approved Treatment for COVID-19
By Miriam Bello - Tue, 11/10/2020 - 13:28
After Pfizer’s announcement yesterday, the world welcomes another gratifying news today.
Influenza Season Meets COVID-19
By Miriam Bello - Thu, 10/15/2020 - 17:09
COVID-19 is far from being over but seven months facing the pandemic have make the sector resilient.
Patent Expirations Loom Over Big Pharma
By - Thu, 09/19/2019 - 17:59
Innovation is at the core of every pharmaceutical company’s success.
As R&D Costs Increase, the Industry Must Find Innovative Ways to Bring Them Down
By - Thu, 09/19/2019 - 17:52
R&D investment in life sciences continues unabated, leading to record-level pipelines for new medications.However,smaller returns on investment in R&D and a wave of patent expirations may dampen the steady growth of the global pharmaceutical industry